Critical Outcome Technologies Seeks to Redefine Personalized Cancer Care With Project ROSALIND ROSALIND, a patent-pending cancer cell simulation, will be introduced at the upcoming BIO...
Critical Outcome Technologies Receives Orphan Drug Designation For COTI-2 Designation for treatment of ovarian cancer provides further support for the clinical development of COTI-2 LONDON...
Critical Outcome Technologies to Commence Trading in U.S. on OTCQB Under Symbol COTQF Enhancing investor access and awareness in the U.S. market LONDON, ONTARIO--(Marketwired - Jun 16, 2014...
Sun, Aug 25, 2013 12:00 - Critical Outcome Technologies, Inc. (COTQF: OTC Pink Current) - Piggyback Qualified - Effective Sun, Aug 25, 2013, COTQF is designated with the status of piggyback...
Fri, Jul 26, 2013 12:00 - Critical Outcome Technologies, Inc. (COTQF: OTC Link) - Venue Change - The symbol, COTQF, no longer trades on Grey Market. As of Fri, Jul 26, 2013, COTQF trades on OTC...
Fri, Jul 26, 2013 12:00 - Critical Outcome Technologies, Inc. (COTQF: OTC Pink Current) - Tier Change - The symbol, COTQF, no longer is classified as Grey Market. As of Fri, Jul 26, 2013, COTQF...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
26 | 0 | 0 | 0.0001 | 0.0001 | 0.0001 | 0 | 0 | CS |
52 | 0 | 0 | 0.0001 | 0.0001 | 0.0001 | 0 | 0 | CS |
156 | 9.0E-5 | 900 | 1.0E-5 | 0.0001 | 1.0E-5 | 591 | 0.0001 | CS |
260 | -0.04242 | -99.7648165569 | 0.04252 | 0.95 | 1.0E-5 | 5219 | 0.08658785 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.